Infant Bacterial (Sweden) Probability of Future Stock Price Finishing Over 43.34
| IBT-B Stock | SEK 39.40 0.60 1.55% |
Infant |
Infant Bacterial Target Price Odds to finish over 43.34
The tendency of Infant Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over kr 43.34 or more in 90 days |
| 39.40 | 90 days | 43.34 | about 22.07 |
Based on a normal probability distribution, the odds of Infant Bacterial to move over kr 43.34 or more in 90 days from now is about 22.07 (This Infant Bacterial Therapeutics probability density function shows the probability of Infant Stock to fall within a particular range of prices over 90 days) . Probability of Infant Bacterial price to stay between its current price of kr 39.40 and kr 43.34 at the end of the 90-day period is about 16.43 .
Assuming the 90 days trading horizon Infant Bacterial Therapeutics has a beta of -0.84. This usually indicates as returns on the benchmark increase, returns on holding Infant Bacterial are expected to decrease at a much lower rate. During a bear market, however, Infant Bacterial Therapeutics is likely to outperform the market. Additionally Infant Bacterial Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Infant Bacterial Price Density |
| Price |
Predictive Modules for Infant Bacterial
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Infant Bacterial. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Infant Bacterial Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Infant Bacterial is not an exception. The market had few large corrections towards the Infant Bacterial's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Infant Bacterial Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Infant Bacterial within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.64 | |
β | Beta against Dow Jones | -0.84 | |
σ | Overall volatility | 8.25 | |
Ir | Information ratio | -0.1 |
Infant Bacterial Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Infant Bacterial for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Infant Bacterial can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Infant Bacterial had very high historical volatility over the last 90 days | |
| Infant Bacterial has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (44.99 M) with profit before overhead, payroll, taxes, and interest of 12 K. | |
| Infant Bacterial Therapeutics has accumulated about 386.75 M in cash with (55.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 48.15, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Infant Bacterial Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Infant Stock often depends not only on the future outlook of the current and potential Infant Bacterial's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Infant Bacterial's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 386.8 M | |
| Shares Float | 10 M |
Infant Bacterial Technical Analysis
Infant Bacterial's future price can be derived by breaking down and analyzing its technical indicators over time. Infant Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Infant Bacterial Therapeutics. In general, you should focus on analyzing Infant Stock price patterns and their correlations with different microeconomic environments and drivers.
Infant Bacterial Predictive Forecast Models
Infant Bacterial's time-series forecasting models is one of many Infant Bacterial's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Infant Bacterial's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Infant Bacterial
Checking the ongoing alerts about Infant Bacterial for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Infant Bacterial help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Infant Bacterial had very high historical volatility over the last 90 days | |
| Infant Bacterial has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (44.99 M) with profit before overhead, payroll, taxes, and interest of 12 K. | |
| Infant Bacterial Therapeutics has accumulated about 386.75 M in cash with (55.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 48.15, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Additional Tools for Infant Stock Analysis
When running Infant Bacterial's price analysis, check to measure Infant Bacterial's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infant Bacterial is operating at the current time. Most of Infant Bacterial's value examination focuses on studying past and present price action to predict the probability of Infant Bacterial's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infant Bacterial's price. Additionally, you may evaluate how the addition of Infant Bacterial to your portfolios can decrease your overall portfolio volatility.